Springer

SHERPA: Unknown

People

  1. Stein
    Stein
  2. Levine
    Levine
  3. Tallman
    Tallman
  4. Lowe
    Lowe
  5. Berman
    Berman
  6. Devlin
    Devlin
  7. Diamond
    Diamond
  8. Goldberg
    Goldberg
  9. Hamadeh
    Hamadeh
  10. Hultcrantz
    Hultcrantz

Groups

  1. Department of Medicine (22)
  2. Hematologic Malignancies, Division of (21)
  3. Center for Hematologic Malignancies (20)
  4. Adult Leukemia (13)
  5. Executive Committee, Center for Hematologic Malignancies (7)
  6. GSK Faculty (6)
  7. Center for Molecular Imaging and Biotechnology (CMIB) (3)
  8. Center for Molecular Imaging and Biotechnology (3)
  9. Human Oncology and Pathogenesis Program (3)
  10. Sloan Kettering Institute Faculty (3)
Search Within
  1. "Annals of Hematology"
Formats
  1. Journal Article (19)
  2. Meeting Abstract (16)
Groups
  1. Department of Medicine (22)
  2. Hematologic Malignancies, Division of (21)
  3. Center for Hematologic Malignancies (20)
  4. Adult Leukemia (13)
  5. Executive Committee, Center for Hematologic Malignancies (7)
  6. GSK Faculty (6)

More Groups

People
  1. Martin Tallman (8)
  2. Eytan Stein (4)
  3. Ross Levine (3)
  4. Carl Landgren (2)
  5. Chong Chen (2)
  6. Dan Douer (2)

More People

Years
  1. 2024 (5)
  2. 2023 (2)
  3. 2022 (1)
  4. 2019 (2)
  5. 2017 (6)
  6. 2016 (4)

More Years

Publications
  1. Annals of Hematology (35)

Results (35)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Racial and ethnic disparities in outcomes of diffuse large B cell lymphoma in adolescent and young adults: A SEER database analysis
    Journal Article

    Aqeel, S. B.; Faisal, M. S.; Akhtar, O. S.; Attwood, K.; George, A.; Advani, P.; Epperla, N.; Torka, P.
    Annals of Hematology (2024)

    Fulltext@MSK | Save
  • Real-world experience with iron chelation therapy in transfusion-dependent thalassemia: Impact of the oral chelators’ era
    Journal Article

    Pines, M.; Kleinert, D.; Thomas, C.; Mensah, C.; Musallam, K. M.; Sheth, S.
    Annals of Hematology (2024)

    Fulltext@MSK | Save
  • Rosai-Dorfman-Destombes disease in adults: A single center experience
    Journal Article

    Leung, E.; Pryma, C.; Murphy, S.; Harrison, R.; Peterson, E.; Tsang, P. W. K.; Varghese, J.; You, X.; Slack, G. W.; Skinnider, B. F.; more...
    Annals of Hematology (2024)

    Fulltext@MSK | Save
  • Hematocrit control and thrombotic risk in patients with polycythemia vera treated with ruxolitinib in clinical practice
    Journal Article

    Chojecki, A.; Boselli, D.; Dortilus, A.; Hamadeh, I.; Begley, S.; Chen, T.; Bose, R.; Podoltsev, N.; Zeidan, A. M.; Balmaceda, N. B.; more...
    Annals of Hematology (2024)

    Fulltext@MSK | Save
  • A multicenter phase Ib trial of the histone deacetylase inhibitor entinostat in combination with pembrolizumab in patients with myelodysplastic syndromes/neoplasms or acute myeloid leukemia refractory to hypomethylating agents
    Journal Article

    Bewersdorf, J. P.; Shallis, R. M.; Sharon, E.; Park, S.; Ramaswamy, R.; Roe, C. E.; Irish, J. M.; Caldwell, A.; Wei, W.; Yacoub, A.; more...
    Annals of Hematology (2024)

    Fulltext@MSK | Save
  • Veno-occlusive disease risk and other outcomes in patients with B-cell precursor acute lymphoblastic leukemia who received inotuzumab ozogamicin and proceeded to hematopoietic stem cell transplantation: A registry-based, observational study
    Meeting Abstract

    Stelljes, M.; de Lima, M.; Kebriaei, P.; Lanza, F.; Cho, C.; Popradi, G.; Zhang, M. J.; Zhang, F.; Welch, V.; Tikka, S.; more...
    Annals of Hematology (2023)

    Fulltext@MSK | Save
  • RE-MIND2: Comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola-BR), CAR-T therapies, and lenalidomide/rituximab (R2) based on real-world data in patients with relapsed/refractory diffuse large B-cell lymphoma
    Journal Article

    Nowakowski, G. S.; Yoon, D. H.; Mondello, P.; Joffe, E.; Peters, A.; Fleury, I.; Greil, R.; Ku, M.; Marks, R.; Kim, K.; more...
    Annals of Hematology (2023)

    Fulltext@MSK | Save
  • Phase 1 study of anti-CD47 monoclonal antibody CC-90002 in patients with relapsed/refractory acute myeloid leukemia and high-risk myelodysplastic syndromes
    Journal Article

    Zeidan, A. M.; DeAngelo, D. J.; Palmer, J.; Seet, C. S.; Tallman, M. S.; Wei, X.; Raymon, H.; Sriraman, P.; Kopytek, S.; Bewersdorf, J. P.; more...
    Annals of Hematology (2022)

    Fulltext@MSK | Save
  • RAS mutations confer an increased risk for relapse in patients with AML receiving induction chemotherapy
    Meeting Abstract

    Ball, B.; Goldberg, A.; Tallman, M.; Stein, E.
    Annals of Hematology (2019)

    Fulltext@MSK | Save
  • Safety and clinical activity of mutant IDH1 inhibitor IVOSIDENIB (IVO; AG-120) in combination with AZACITIDINE (AZA) for newly diagnosed acute myeloid leukemia (ND AML)
    Meeting Abstract

    DiNardo, C.; Stein, A.; Stein, E.; Fathi, A.; Frankfurt, O.; Schuh, A.; Döhner, H.; Martinelli, G.; Patel, P.; Raffoux, E.; more...
    Annals of Hematology (2019)

    Fulltext@MSK | Save